Announcements Trials
Browse Landscape

Phase

Phase 1 24Phase 2 22Phase NA 8Phase 1/2 6Phase EARLY_PHASE1 2Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Obesity 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Immunoenzyme Techniques × Clear all
NCT00859989 2013-12-18

A Weight-Loss Program in Helping Obese Black Women Lose Weight

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
BreastOther

Body Weight Changes, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡